396 Followers on Owler

GlycoMimetics

is a Maryland-based clinical-stage biotechnology company that develops and commercializes glycobiology therapies for cancer and inflammatory diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

GlycoMimetics

is a Maryland-based clinical-stage biotechnology company that develops and commercializes glycobiology therapies for cancer and inflammatory diseases... Read more
GlycoMimetics CEO: Harout Semerjian

CEO

Harout Semerjian

CEO Approval Rating

83/100

2003

PublicNASDAQGLYC

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
$ < 1M
Employees
50
Funding
$119.8M
Acquisitions
1

News

Acquisition
Oct 29, 2024
Citybizlist
GlycoMimetics acquired Crescent Biopharma for undisclosed amount

GlycoMimetics Competitors

1Inovio
2Xalud
3Vera
4Supernus
5Vanda
6Genentech
7Galecto
8AbbVie
9Biogen
10Gilead
Unlock 21 + competitors

Trending Companies